Parkinson's Disease and Biology

View overview page
1:43
The biological definition of Parkinson’s disease
Tiago Outeiro • 25 Jun 2022
4:53
Advances in the genetics of Parkinson’s disease
Heinz Reichmann • 22 Mar 2022
3:28
Current understanding of the pathophysiology of RBD
Alberto Ramos • 12 Apr 2022
2:25
Identifying the risk factors for parasomnias
Alberto Ramos • 12 Apr 2022
2:48
The emergence of COVID-19-induced parkinsonism
Angelo Antonini • 29 Mar 2022
1:13
The role of phosphoinositides in Parkinson’s disease pathology
Ronit Sharon • 18 Mar 2022
2:50
Insights into Parkinson’s disease pathology: α-syn & phosphoinositides
Ronit Sharon • 18 Mar 2022
4:06
Establishing the link between the Parkinson’s Disease and gut microbiota
Valentina Leta • 24 Mar 2022
1:22
Brain region-specific changes in α-synuclein conformations in Parkinson’s disease
Tim Bartels • 17 Mar 2022
1:32
AD/PD highlights: α-synuclein PET tracer
Tiago Outeiro • 18 Mar 2022
2:15
Hippocampus atrophy and white matter lesions in PD & AD
Ivan Rektor • 17 Apr 2022
2:05
Hippocampal volume changes in Parkinson’s disease
Ivan Rektor • 17 Mar 2022
3:52
In vivo interactions between Nedd4 ubiquitin ligases and α-synuclein in Parkinson’s disease models
James Conway • 11 Mar 2022
4:45
How can the gut microbiome modulate the peripheral and brain immune systems?
Giulio Pasinetti • 18 Mar 2022
1:34
Is α-synuclein aggregation a cause or consequence of Parkinson’s disease?
Tiago Outeiro • 18 Mar 2022
1:37
How does α-synuclein propagate from cell to cell?
Tiago Outeiro • 18 Mar 2022
The content of VJNeurology is intended for healthcare professionals